08217.HK
Ju Fu Tang Biotech Holdings Co., Ltd
HKSE · Industrials · Engineering & Construction · HK
HKD 0.11
+0.88%Year over year
Reported trailing growth
- Revenue
- +30.2%
- EBITDA
- +783.7%
- EBIT
- —
- EPS
- +947.6%
- Free cash flow
- -0.7%
- Operating cash flow
- -0.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -28.9%
- EBITDA
- -20.1%
- EBIT
- -19.0%
- Net income
- +495.3%
- EPS
- +495.9%
- Free cash flow
- -37.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026